The QUEST initiative: QUality of life Evaluation STudy: Assessing Health Related Quality of Life in patients receiving medicinal cannabis
Type of Study/Intervention
Form of MS
Relapsing remitting MS/Secondary progressive MS/Primary progressive MS/Clinically isolated syndrome/Relapsing MS/People without MS
You are invited to take part in a research study exploring quality of life in patients accessing medicinal cannabis. People accessing medicinal cannabis may have a range of conditions and symptoms that impact their quality of life. We would like to know how these conditions and symptoms impact quality of life and if this changes over time while accessing medicinal cannabis. The results from this study will help future patients with these conditions to make better informed decisions about their treatment.
Visit The QUEST Initiative website for a detailed overview about medication cost, participating doctors and how to enrol.
• 18+ years of age and over
• People with and without MS
• Male and Female
• Eligible for medicinal cannabis as a form of treatment
Take the Am I eligible survey to find out if you can potentially enrol
• Have not taken any type of prescribed cannabis therapy for four weeks before enrolling in the study
• History of psychosis or schizophrenia
View the eligibility criteria: https://www.thequestinitiative.com/patients/
Anticipated start date
Already commenced December 2020
Details of the trial can be found at clinicaltrials.gov or on the ANZCTR clinical trials database.
17 Feb 2021